The Continuing Ophthalmic Challenge of Bartonella henselae
Daniel M. Albert, MD, MS, Ali R. Salman, MD, Kevin L. Winthrop, MD, MPH and 1 more
Ophthalmology Science · 2021
doi:10.1016/j.xops.2021.100048 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Purpose: To better understand the history and epidemiology of Bartonella henselae infections of the eye and adnexa, and their relationship to cat scratch disease (CSD). We also assess B. henselae infection as a public health threat. Methods: We reviewed the available literature concerning B. henselae infections of the eye and CSD, and attempted calculation of the incidence and prevalence of both B. henselae eye infections and CSD from the database of the Rochester Epidemiology Project. Results: It took nearly a century of determined effort to reveal that Henri Parinaud’s oculoglandular syndrome (POGS) (1889) and Leber’s stellate retinitis (1916) were the result of B. henselae infection and are subtypes of CSD. These ocular infections remain of clinical, epidemiologic, and public health concern to ophthalmologists with many unanswered questions. Their incidence and prevalence have yet to be accurately determined. Our attempt to achieve this through the Rochester Epidemiology Project database suggests a major obstacle is inconsistent with nonunanimous diagnostic terminology and coding. Conclusions: Modern serologic testing and molecular diagnostic techniques offer ophthalmologists the opportunity to make B. henselae infection of the eyes an area of “precision medicine.” For this to happen, greater awareness and teaching about this disease, updated terminology, and a greater clinical and research effort are required.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.